Sinopharm Group Co. Ltd. (X2S1)
FSX
Real-time Data
06:00 AM
Day's Range
9.0052 wk Range
8.70Overview - X2S1 - Sinopharm Group Co. Ltd.
Key Statistics
Valuation
Enterprise Value
12.21B
P/E (Trailing)
‪6.09‬
Price / Sales (TTM)
‪0.0096‬
Price / Book
‪0.53‬
EV / EBITDA
‪5.01‬
Profitability
Profit Margin
‪1.23%‬
Operating Margin
‪2.18%‬
Return on Assets
‪2.62%‬
Return on Equity
‪8.10%‬
Ownership
Shares Outstanding
3.12B
Float
254.92M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.44‬
50-Day Avg
‪9.28‬
200-Day Avg
‪10.45‬
Dividends
Payout Ratio
‪29.43%‬
Frequency
Annual
Market Cap - X2S1 - Sinopharm Group Co. Ltd.
Peers - X2S1 - Sinopharm Group Co. Ltd.
Peer Comparison
Compared with companies in Medical Distribution listed on FSX.
- X2S1FSXSinopharm Group Co. Ltd.5.61BMarket Cap-18.64%52-week change6.10P/E (Trailing)‪1.23%‬Profit Margin
- ABGFSXCencora, Inc.3.58TMarket Cap+39.27%52-week change17.18P/E (Trailing)‪54.77%‬Profit Margin
- MCKFSXMcKesson Corporation83.01BMarket Cap+19.52%52-week change22.32P/E (Trailing)‪1.11%‬Profit Margin
- CLHFSXCardinal Health Inc.45.29BMarket Cap+35.63%52-week change31.46P/E (Trailing)‪0.67%‬Profit Margin
- S5YAFSXSigma Healthcare Limited19.85BMarket Cap+10.59%52-week change57.33P/E (Trailing)‪6.28%‬Profit Margin
- HS2FSXHenry Schein, Inc.8.35BMarket Cap+21.09%52-week change25.60P/E (Trailing)‪2.96%‬Profit Margin
- S1RFSXShanghai Pharmaceuticals Holding Co. Ltd.4.48BMarket Cap-14.05%52-week change6.10P/E (Trailing)‪2.01%‬Profit Margin
Profile Summary - X2S1 - Sinopharm Group Co. Ltd.
About
Sinopharm Group Co. Ltd. is a prominent player in the pharmaceutical and healthcare industry in China. As a state-owned enterprise, Sinopharm focuses on various aspects of the healthcare system, including the research, development, manufacturing, distribution, and retailing of pharmaceuticals and medical equipment.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
